Literature DB >> 18815424

Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa.

A J Brea-Fernández1, E Pomares, M J Brión, G Marfany, M J Blanco, M Sánchez-Salorio, R González-Duarte, A Carracedo.   

Abstract

BACKGROUND/AIM: Mutations in MERTK, a member of the MER/AXL/TYRO3 receptor kinase family, have been associated with disruption of the Retinal Pigment Epithelium (RPE) phagocytosis pathway and settling of autosomal recessive RP (arRP) in humans. This study reports a novel MERTK mutation (IVS16+1G>T) in a Spanish consanguineous family presenting arRP.
METHODS: 21 genes were screened by high-throughput SNP multiplexing assay. Subsequent direct sequencing was performed in exons and intronic boundaries of the cosegregating gene. The effect of the mutation in mRNA splicing was confirmed by cDNA analysis.
RESULTS: Haplotypic data revealed MERTK cosegregation with RP in affected individuals. MERTK sequencing showed a G-to-T substitution at the first nucleotide of intron 16. Finally, cDNA analysis confirmed the lack of exon 16 in the mRNA splicing process.
CONCLUSIONS: IVS16+1G>T disrupts the splice donor site causing exon 16 skipping. Absence of exon 16 causes a frameshift and, subsequently, the introduction of a premature termination codon into exon 17 creating an altered mRNA transcript with a seriously affected tyrosine kinase domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815424     DOI: 10.1136/bjo.2008.139204

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

1.  Nonsense mutation in MERTK causes autosomal recessive retinitis pigmentosa in a consanguineous Pakistani family.

Authors:  Amber Shahzadi; S Amer Riazuddin; Shahbaz Ali; David Li; Shaheen N Khan; Tayyab Husnain; Javed Akram; Paul A Sieving; J Fielding Hejtmancik; Sheikh Riazuddin
Journal:  Br J Ophthalmol       Date:  2010-06-10       Impact factor: 4.638

Review 2.  TAM receptor signaling and autoimmune disease.

Authors:  Carla V Rothlin; Greg Lemke
Journal:  Curr Opin Immunol       Date:  2010-10-26       Impact factor: 7.486

3.  Antagonistic Coevolution of MER Tyrosine Kinase Expression and Function.

Authors:  Amanda L Evans; Jack W D Blackburn; Kyle Taruc; Angela Kipp; Brennan S Dirk; Nina R Hunt; Stephen D Barr; Jimmy D Dikeakos; Bryan Heit
Journal:  Mol Biol Evol       Date:  2017-07-01       Impact factor: 16.240

4.  A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells.

Authors:  Zuoan Yi; Li Li; Glenn K Matsushima; H Shelton Earp; Bo Wang; Roland Tisch
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

5.  An ENU-induced mutation in the Mertk gene (Mertknmf12) leads to a slow form of retinal degeneration.

Authors:  Dennis M Maddox; Wanda L Hicks; Douglas Vollrath; Matthew M LaVail; Jürgen K Naggert; Patsy M Nishina
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

6.  Mechanical Stress and Single Nucleotide Variants Regulate Alternative Splicing of the MYLK Gene.

Authors:  Joseph B Mascarenhas; Alex Y Tchourbanov; Hanli Fan; Sergei M Danilov; Ting Wang; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

7.  Novel mutations in MERTK associated with childhood onset rod-cone dystrophy.

Authors:  Donna S Mackay; Robert H Henderson; Panagiotis I Sergouniotis; Zheng Li; Phillip Moradi; Graham E Holder; Naushin Waseem; Shomi S Bhattacharya; Mohammed A Aldahmesh; Fowzan S Alkuraya; Brian Meyer; Andrew R Webster; Anthony T Moore
Journal:  Mol Vis       Date:  2010-03-09       Impact factor: 2.367

8.  Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis.

Authors:  Jun Wu; Carl Ekman; Andreas Jönsen; Gunnar Sturfelt; Anders A Bengtsson; Anders Gottsäter; Bengt Lindblad; Elisabet Lindqvist; Tore Saxne; Björn Dahlbäck
Journal:  Arthritis Res Ther       Date:  2011-04-15       Impact factor: 5.156

9.  A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases.

Authors:  Elsebet Ostergaard; Morten Duno; Mustafa Batbayli; Kaj Vilhelmsen; Thomas Rosenberg
Journal:  Mol Vis       Date:  2011-06-04       Impact factor: 2.367

10.  MERTK interactions with SH2-domain proteins in the retinal pigment epithelium.

Authors:  Shameka J Shelby; Karen Colwill; Sirano Dhe-Paganon; Tony Pawson; Debra A Thompson
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.